Buy Translate Bio Inc Stock | TBIO Stock Price & Latest News | Public
TBIO

Translate Bio Inc

$0.00 (0.00%)Today

    About TBIO

    Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidates include MRT5005 for the treatment of cystic fibrosis; and for the tr...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0.32
    0.02
    -0.28
    -0.58
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    $0.32

    Actual EPS
    Q3 2020

    Stats

    Market Cap$938,44M
    Volume53,15k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$28.09
    1 Year Low$6.80
    Open$12.59
    High$13.16
    Low$12.52

    Buy any stock with any amount of money.

    Download the App
    Download the app